The global detachable coil market was valued at approximately $414 million in 2025. The market is expected to grow at a compound annual growth rate (CAGR) of approximately 0.2%, reaching approximately $418 million by 2032.
This report covers bare platinum detachable coils and coated detachable coils used in the endovascular treatment of intracranial aneurysms. The report quantifies unit sales, procedure numbers, average selling prices (ASPs), market values, growth rates, and company shares, with historical data back to 2022 and forecasts through 2032.
The primary constraint on market growth is the increasing adoption of alternative endovascular technologies. Flow diverters and intrasaccular devices are gaining clinical acceptance and expanding their approved indications, reducing reliance on coils in aneurysm treatment and limiting procedural volume growth in this segment.
Improved imaging technologies and continued advances in coil design provide an offsetting demand driver. Better detection of unruptured aneurysms is expanding the treated patient population, while improvements in coil geometry, softness, and deliverability are maintaining coiling as the preferred treatment approach across a broad range of aneurysm locations and morphologies.
The growing adoption of flow diverters and intrasaccular devices represents the most significant structural challenge to the detachable coil market. Flow diverters redirect blood away from the aneurysm, promoting clot formation within the sac, and are primarily used for large or giant wide-necked aneurysms. Intrasaccular devices that scaffold the aneurysm neck are gaining traction following regulatory approvals in major markets, with several products either recently approved or in the process of gaining market access. As these technologies expand their indications and surgeon familiarity grows, they continue to displace coils from procedures where either approach was previously viable.
Improved imaging technologies are providing a partially offsetting demand dynamic. CT angiography, cerebral angiography, and MRI are detecting aneurysms that would previously have remained undiagnosed, expanding the pool of patients who are candidates for endovascular treatment. This trend is also driving a shift toward treating smaller aneurysms, where microfiber coil systems are well suited to the smaller aneurysm volumes involved and contribute incremental unit demand to the market.
Advances in coil construction and design continue to improve clinical outcomes and sustain physician preference for coiling in appropriate cases. Complex shaped coils that deploy in multiple directions have replaced earlier helical designs that expanded primarily in one plane, improving the quality and completeness of aneurysm sac occlusion. Major clinical evidence, including data from the International Subarachnoid Aneurysm Trial, has reinforced the long-term efficacy of endovascular coiling compared to neurosurgical clipping for ruptured intracranial aneurysms, maintaining the clinical rationale for coil use across appropriate indications.
Medtronic held the second-leading position in the detachable coil market in 2025. The company's AXIUM detachable coil system is designed for optimal coil delivery, deployment, and detachment into the aneurysm, addressing the procedural precision requirements of complex endovascular cases. Medtronic's presence in both the detachable coil market and the broader neurovascular space, including flow diverter platforms, positions the company across multiple treatment modalities as the competitive landscape evolves.
Terumo was the third-leading competitor in the detachable coil market in 2025. The company competes through its MicroPlex coil system and the Hydrocoil embolic system, offering coverage across both bare platinum and coated coil categories. Terumo's portfolio addresses a range of aneurysm sizes and treatment scenarios, and its position in the coated coil segment differentiates it within a market where bare platinum products continue to dominate by volume.
6 charts and 32 figures illustrating market segmentation and performance metrics.
Methodology Appendix, Abbreviation and Acronym Glossary explaining all data definitions and modeling assumptions.
Licensing options: single-user, site, and enterprise.
This report covers bare platinum detachable coils and coated detachable coils used in the endovascular treatment of intracranial aneurysms. The report quantifies unit sales, procedure numbers, average selling prices (ASPs), market values, growth rates, and company shares, with historical data back to 2022 and forecasts through 2032.
The primary constraint on market growth is the increasing adoption of alternative endovascular technologies. Flow diverters and intrasaccular devices are gaining clinical acceptance and expanding their approved indications, reducing reliance on coils in aneurysm treatment and limiting procedural volume growth in this segment.
Improved imaging technologies and continued advances in coil design provide an offsetting demand driver. Better detection of unruptured aneurysms is expanding the treated patient population, while improvements in coil geometry, softness, and deliverability are maintaining coiling as the preferred treatment approach across a broad range of aneurysm locations and morphologies.
Market Overview
Detachable coils are an established treatment for intracranial aneurysm occlusion, supported by a long-term clinical evidence base that demonstrates their safety and efficacy relative to open neurosurgical clipping. The market occupies a mature position within the broader neurovascular intervention segment, with near-flat growth reflecting both the clinical durability of coil technology and the competitive pressure from newer endovascular alternatives that are gradually displacing coils from a growing share of eligible aneurysm cases.The growing adoption of flow diverters and intrasaccular devices represents the most significant structural challenge to the detachable coil market. Flow diverters redirect blood away from the aneurysm, promoting clot formation within the sac, and are primarily used for large or giant wide-necked aneurysms. Intrasaccular devices that scaffold the aneurysm neck are gaining traction following regulatory approvals in major markets, with several products either recently approved or in the process of gaining market access. As these technologies expand their indications and surgeon familiarity grows, they continue to displace coils from procedures where either approach was previously viable.
Improved imaging technologies are providing a partially offsetting demand dynamic. CT angiography, cerebral angiography, and MRI are detecting aneurysms that would previously have remained undiagnosed, expanding the pool of patients who are candidates for endovascular treatment. This trend is also driving a shift toward treating smaller aneurysms, where microfiber coil systems are well suited to the smaller aneurysm volumes involved and contribute incremental unit demand to the market.
Advances in coil construction and design continue to improve clinical outcomes and sustain physician preference for coiling in appropriate cases. Complex shaped coils that deploy in multiple directions have replaced earlier helical designs that expanded primarily in one plane, improving the quality and completeness of aneurysm sac occlusion. Major clinical evidence, including data from the International Subarachnoid Aneurysm Trial, has reinforced the long-term efficacy of endovascular coiling compared to neurosurgical clipping for ruptured intracranial aneurysms, maintaining the clinical rationale for coil use across appropriate indications.
Market Drivers
Improved Imaging Technologies
Advances in imaging have allowed for increased detection of unruptured intracranial aneurysms. Cerebral angiography, CT, and MRI can all identify unruptured aneurysms, and as imaging quality and availability continue to improve globally, more patients are being identified as candidates for endovascular treatment. This growth in the diagnosed patient population supports incremental unit volume for detachable coils over the forecast period. Improved early detection is also driving a clinical trend toward the treatment of smaller aneurysms, where microfiber coil systems are well suited and add incremental unit demand. The ISAT study, conducted by the International Subarachnoid Aneurysm Trial Collaborative Group, demonstrated that endovascular coil treatment is significantly more likely to result in survival free of disability at one year following subarachnoid hemorrhage compared to neurosurgical treatment, reinforcing physician preference for coiling in anatomically appropriate cases.Improved Coil Construction and Design
The construction and design of detachable coils have improved considerably since the segment was established. Advancements in geometry, softness, and deliverability have produced more durable coils capable of navigating complex anatomy and filling aneurysm sacs more thoroughly and consistently. The market has trended toward softer, shorter coil formats that provide more precise placement and reduce the risk of coil migration. Complex shaped coils that deploy in multiple directions have broadened the range of aneurysm morphologies that can be effectively treated by coiling, allowing surgeons to frame the aneurysm before filling the sac with additional coils for complete occlusion. These design advances maintain coiling as the preferred approach across a wide range of aneurysm types and sustain demand for coil units even as alternative technologies grow in adoption.Market Limiters
Introduction of Competing Technologies
Flow diverter devices that redirect blood away from the aneurysm, promoting clot formation within the sac, are cannibalizing significant market share from detachable coils. These devices are primarily used to treat large or giant, wide-necked brain aneurysms, but clinical indications are expanding as physician experience accumulates. Intrasaccular devices that scaffold the aneurysm neck are also gaining traction. MicroVention's WEB device, which received CE marking a decade ago, is already seeing high adoption rates following FDA premarket approval, while Medtronic and Cerus Endovascular are working to enter this segment with their own competing products. As these technologies grow in clinical familiarity and expand approved indications, they continue to displace detachable coils in cases where either approach was previously considered viable, creating sustained competitive pressure on coil procedure volumes and market value growth.Morphological Constraints on Coiling Eligibility
Not all intracranial aneurysms are amenable to treatment by coiling, which defines a natural boundary on the total addressable procedure volume for detachable coils. Aneurysm location, morphology, and anatomical characteristics influence the treatment decision between endovascular coiling and surgical clipping. Middle cerebral artery aneurysms are more frequently clipped due to easier surgical access in that region, while posterior artery aneurysms are coiled the majority of the time. Clipping is generally preferred for aneurysms with a wide neck or a dome-to-neck ratio below 1.5. Coiling is preferred when the aneurysm has calcified walls, which are difficult to treat surgically. These morphological considerations define a structural ceiling on the share of aneurysm cases that can be directed toward coil-based treatment, and this constraint is not expected to change meaningfully over the forecast period.Market Coverage and Data Scope
- Quantitative coverage: Procedure numbers, market size, market shares, market forecasts, growth rates, units sold, and average selling prices.
- Qualitative coverage: Growth trends, market limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles and product portfolios, and technology trends shaping demand.
- Time frame: Base year 2025, forecasts 2026 to 2032, historical data 2022 to 2024.
- Data sources: Primary interviews with neurovascular device industry leaders and neurosurgeons, regulatory data, hospital procurement data, import and export data, and the iData Research internal database.
- Care settings: Hospitals and neurovascular intervention centers.
Markets Covered and Segmentation
The detachable coil market is analyzed across two material categories, each assessed by unit volume, ASP, and market value with historical and forecast data:
- Bare Platinum Detachable Coils
- Coated Detachable Coils
Competitive Analysis
Stryker was the leader in the global detachable coil market in 2025, with a primary focus on the bare platinum segment. The company's GDC 360 detachable coil is widely regarded as the gold standard for neurovascular aneurysm occlusion and played a foundational role in establishing endovascular coiling as a primary treatment modality for intracranial aneurysms. Stryker's deep heritage in this segment, combined with the clinical evidence base built around the GDC platform, supports its continued leadership position across major global markets.Medtronic held the second-leading position in the detachable coil market in 2025. The company's AXIUM detachable coil system is designed for optimal coil delivery, deployment, and detachment into the aneurysm, addressing the procedural precision requirements of complex endovascular cases. Medtronic's presence in both the detachable coil market and the broader neurovascular space, including flow diverter platforms, positions the company across multiple treatment modalities as the competitive landscape evolves.
Terumo was the third-leading competitor in the detachable coil market in 2025. The company competes through its MicroPlex coil system and the Hydrocoil embolic system, offering coverage across both bare platinum and coated coil categories. Terumo's portfolio addresses a range of aneurysm sizes and treatment scenarios, and its position in the coated coil segment differentiates it within a market where bare platinum products continue to dominate by volume.
Technology and Practice Trends
- Softer and shorter coil formats: The market trend toward softer, shorter coils provides more precise placement within complex aneurysm geometries and reduces the risk of coil migration or compaction over time.
- Complex shaped coil designs: Coils that deploy in multiple directions have replaced earlier single-plane helical formats, improving full-sac occlusion and enabling framing strategies that support complete aneurysm filling.
- Flow diverter adoption: Flow diverters are gaining clinical acceptance for large and giant wide-necked aneurysms, increasingly displacing coils in cases where both treatment types are technically viable.
- Intrasaccular device competition: Intrasaccular scaffolding devices are achieving growing adoption in major markets following regulatory approvals, expanding the range of alternative treatment options that compete with coil-based therapy.
- Imaging-driven diagnosis growth: Improvements in CT angiography, MRI, and cerebral angiography are increasing the detection rate of unruptured aneurysms, expanding the treated patient population and supporting incremental coil unit demand.
- Microfiber coils for small aneurysms: The clinical shift toward treating smaller aneurysms, enabled by better imaging and earlier diagnosis, is increasing demand for microfiber coil systems suited to smaller aneurysm volumes.
Geography
This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.Deliverables
67 pages of detailed narrative analysis, tables, and figures.6 charts and 32 figures illustrating market segmentation and performance metrics.
Methodology Appendix, Abbreviation and Acronym Glossary explaining all data definitions and modeling assumptions.
Licensing options: single-user, site, and enterprise.
Why This Report
- Where are the remaining growth opportunities within the global detachable coil market as competing technologies expand their clinical indications through 2032?
- How are flow diverters and intrasaccular devices displacing coils, and which aneurysm types and locations remain most favorable for coil-based treatment?
- What is the commercial impact of imaging-driven increases in unruptured aneurysm detection on coil procedure volumes and unit sales?
- How are improvements in coil geometry, softness, and deliverability maintaining clinical preference for coiling in appropriate cases?
- What is the outlook for bare platinum versus coated coil categories, and how is product mix shifting across these two segments?
- Which companies lead the market and how are they positioning their coil portfolios alongside competing neurovascular platforms?
- How do aneurysm morphology and location constraints define the natural ceiling on coil-eligible procedure volume?
- What are the key risks to the coil market, including the pace of competing technology adoption, reimbursement structures, and the expansion of intrasaccular device indications?
Table of Contents
Research Methodology
Detachable Coil Market
List of Charts
List of Figures
